Skip to content

Torpedo Therapeutics

YC W22 · Active · High-precision, closed-loop neuromodulation devices

Competitors

Adjacent

Also from W22

All of W22

About Torpedo Therapeutics

We are building high-precision implantable neuromodulation devices that can sense and stimulate neural activity in the brain with the goal of transforming the efficacy and adoption of deep brain stimulation (DBS), an existing FDA-approved therapy used to treat Parkinson’s, essential tremor and epilepsy.

YC batch
W22 · Winter 2022
Status, per YC
Active
Category
Other
Team size
5
Location
Boston, MA, USA
Checked
36m ago

YC tags: Neurotechnology, Medical Devices, Biotech

Torpedo Therapeutics in W22: 398 companies, 44% AI

Torpedo Therapeutics: questions

Which YC batch was Torpedo Therapeutics in?

Torpedo Therapeutics was in Y Combinator's Winter 2022 batch (W22).

Is Torpedo Therapeutics still active?

Y Combinator lists Torpedo Therapeutics as active.

Where is Torpedo Therapeutics based?

Torpedo Therapeutics lists Boston, MA, USA as its location on YC's directory.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.